TY - JOUR
T1 - Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus
AU - Li, Anna Fen Yau
AU - Hsu, Po Kuei
AU - Tzao, Ching
AU - Wang, Yi Ching
AU - Hung, I. Chun
AU - Huang, Min Hsiung
AU - Hsu, Han Shui
PY - 2009/9
Y1 - 2009/9
N2 - Aims: Our study investigates the significance of the expression of Wnt pathway proteins including β-catenin, Axin, β-transducin-repeat- containing protein (β-TrCP), and adenomatous polyposis coli (APC) in squamous cell carcinoma of the esophagus (ESCC). Methods: Immunohistochemical analysis was performed on paraffin-embedded tissue specimens from 128 resected ESCC tumors to detect the expression of β-catenin, Axin, β-TrCP, and APC. Correlation between immunoexpression, clinicopathological parameters, and patient survival was analyzed. Results: Increased β-catenin expression was noted in 22 (18.2%) of 121 tumor specimens. Reduced expression of Axin, β-TrCP, and APC was observed in 57 (46.0%) of 124, 29 (24.4%) of 119, and 54 (48.2%) of 119 specimens, respectively. No correlation was found among these protein expressions. Axin protein expression was inversely correlated with tumor invasion depth (P = 0.033). Reduced Axin protein expression, lymph node involvement, and distant metastasis were significant negative predictors for overall survival and disease-free survival on univariate analysis. In multivariate analysis, reduced Axin expression remained a significant prognostic factor for patients with ESCC (P = 0.005). Conclusions: Reduced Axin expression was observed in 46% of ESCC tumor specimens and was associated with poor prognosis in patients with ESCC. Further study is mandatory to elucidate the underlying mechanism responsible for loss of Axin expression and the role of Axin in ESCC tumorigenesis.
AB - Aims: Our study investigates the significance of the expression of Wnt pathway proteins including β-catenin, Axin, β-transducin-repeat- containing protein (β-TrCP), and adenomatous polyposis coli (APC) in squamous cell carcinoma of the esophagus (ESCC). Methods: Immunohistochemical analysis was performed on paraffin-embedded tissue specimens from 128 resected ESCC tumors to detect the expression of β-catenin, Axin, β-TrCP, and APC. Correlation between immunoexpression, clinicopathological parameters, and patient survival was analyzed. Results: Increased β-catenin expression was noted in 22 (18.2%) of 121 tumor specimens. Reduced expression of Axin, β-TrCP, and APC was observed in 57 (46.0%) of 124, 29 (24.4%) of 119, and 54 (48.2%) of 119 specimens, respectively. No correlation was found among these protein expressions. Axin protein expression was inversely correlated with tumor invasion depth (P = 0.033). Reduced Axin protein expression, lymph node involvement, and distant metastasis were significant negative predictors for overall survival and disease-free survival on univariate analysis. In multivariate analysis, reduced Axin expression remained a significant prognostic factor for patients with ESCC (P = 0.005). Conclusions: Reduced Axin expression was observed in 46% of ESCC tumor specimens and was associated with poor prognosis in patients with ESCC. Further study is mandatory to elucidate the underlying mechanism responsible for loss of Axin expression and the role of Axin in ESCC tumorigenesis.
UR - http://www.scopus.com/inward/record.url?scp=68949200132&partnerID=8YFLogxK
U2 - 10.1245/s10434-009-0593-3
DO - 10.1245/s10434-009-0593-3
M3 - Article
C2 - 19582507
AN - SCOPUS:68949200132
SN - 1068-9265
VL - 16
SP - 2486
EP - 2493
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 9
ER -